The natural history of type 1A diabetes

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 2, 2008, Pages 146-155

  Eisenbarth, George S ^a   Jeffrey, Joy ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Anti islet autoimmunity; Autoantibodies; HLA, genetic; Type 1 diabetes

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN; INSULIN; INSULIN ANTIBODY;

ANIMAL; AUTOIMMUNITY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; REVIEW;

ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INSULIN; INSULIN ANTIBODIES; MALE; MICE; MICE, INBRED NOD;

EID: 43249094488     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302008000200002     Document Type: Review

References (55)

1. Eisenbarth GS. Update in type 1 diabetes. J Clin Endocrinol Metab. 2007;92(7):2403-7.
2. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31 Suppl 1:S55-S60.
3. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661-78.
4. Liu E, Eisenbarth GS. Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays. Clin Immunol. 2007;125(2):120-6.
5. Yang Y, Santamaria P. Lessons on autoimmune diabetes from animal models. Clin Sci (Lond). 2006;110(6):627-39.
6. Norris JM, Yin X, Lamb MM, Barriga K, Seifert J, Hoffman M et al. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA. 2007;298(12):1420-8.
7. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med. 1986;314:1360-8.
8. Wildin RS, Freitas A. IPEX and FOXP3: Clinical and research perspectives. J Autoimmun. 2005;25 Suppl:56-62.
9. Su MA, Anderson MS. Aire: an update. Curr Opin Immunol. 2004;16(6):746-52.
10. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4(4):330-6.
11. Mathis D, Benoist C. A decade of AIRE. Nat Rev Immunol. 2007;7(8):645-50.
12. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39(7):857-64.
13. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet. 1996;59(5):1134-48.
14. Pugliese A, Zeller M, Fernandez A, Zalcberg LJ, Bartlett RJ, Ricordi C et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDM2 susceptibility locus for type I diabetes. Nat Genet. 1997;15(3):293-7.
15. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004;36(4):337-8.
16. Marron MP, Raffel LJ, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez LM et al. Insulin-dependent diabetes mellitus (IDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet. 1997;6(8):1275-82.
17. Aly TA, Baschal EE, Jahromi MM, Fernando MS, Babu SR, Fingerlin TE et al. Analysis of SNPs Identifies Major Type 1A Diabetes Locus Telomeric of the MHC. Diabetes. 2007;.
18. Baschal EE, Aly TA, Babu SR, Fernando MS, Yu L, Miao D et al. HLA-DPB1*0402 Protects Against Type 1A Diabetic Autoimmunity in the Highest Risk DR3-DQB1*0201/DR4-DQB1*0302 DAISY Population. diab. 2007;56(Epub ahead of print):2405-9.
19. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med. 1990;322(26):1836-41.
20. Steck AK, Pugliese A, Eisenbarth GS. Prediction of Type IA Diabetes: The Natural History of the Prediabetic Period. In: Eisenbarth GS, editor. Type 1 Diabetes: Molecular, Cellular and Clinical Immunology. 2008.
21. Redondo MJ, Kawasaki E, Mulgrew CL, Noble JA, Erlich HA, Freed BM et al. DR and DQ associated protection from type 1 diabetes: comparison of DRB1*1401 and DQA1*0102-DQB1*0602. J Clin Endocrinol Metab. 2000;85(10):3793-7.
22. Tarn AC, Thomas JM, Dean BM, Ingram D, Schwarz G, Bottazzo GF et al. Predicting insulin-dependent diabetes. Lancet. 1988;I(8590):845-50.
23. Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE et al. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab. 2004;89(7):3474-6.
24. Hanifi MP, de Knijf P, Roep BO, van der AB, Naipal A, Gorus F et al. Genetic structure of IDM1: two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Belgian Diabetes Registry. Diabetes. 1998;47(2):263-9.
25. Inoue K, Ikegami H, Fujisawa T, Noso S, Nojima K, Babaya N et al. Allelic variation in class I K gene as candidate for a second component of MHC-linked susceptibility to type 1 diabetes in non-obese diabetic mice. Diabetologia. 2004;47(4):739-47.
26. Hattori M, Yamato E, Itoh N, Senpuku H, Fujisawa T, Yoshino M et al. Cutting edge: homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in non-obese diabetic mice. J Immunol. 1999;163(4):1721-4.
27. Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR et al. Extreme Genetic Risk for Type 1A Diabetes. Proc Natl Acad Sci USA. 2006;103(38):14074- 9.
28. Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care. 2004;27(6):1399-404.
29. Barker JM, Barriga K, Yu L, Miao D, Erlich H, Norris JN et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab. 2004;89:3896-902.
30. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E. Mature high-affinity immune responses to (pro) insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest. 2004;114(4):589-97.
31. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes. 1996;45(7):926-93.
32. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A. 2007;104(43):17040-5.
33. Wang J, Miao D, Babu S, Yu J, Barker J, Klingensmith G et al. Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab. 2007;92(1):88-92.
34. Vardi P, Ziegler AG, Matthews JH, Dib S, Keller RJ, Ricker AT et al. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care. 1988;11(9):736-9.
35. Palmer JP, Hampe CS, Chiu H, Goel A, Brooks-Worrell BM. Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age? Diabetes. 2005;54 Suppl 2:S62-7.:S62-S67.
36. Achenbach P, Bonifacio E, Williams AJ, Ziegler AG, Gale EA, Bingley PJ. Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives. Diabetologia. 2008;51:488-92
37. Mayr A, Schlosser M, Grober N, Kenk H, Ziegler AG, Bonifacio E et al. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes. Diabetes. 2007;56(6):1527-33.
38. In't VP, Lievens D, De Grijse J, Ling Z, van der AB, Pipeleers-Marichal M et al. Screening for insulitis in adult autoantibody-positive organ donors. Diabetes. 2007;56(9):2400-4.
39. Gianani R, Putnam A, Still T, Yu L, Miao D, Gill RG et al. Initial results of screening of non - diabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab. 2006;91:1855-61.
40. Foulis AK, McGill M, Farquharson MA. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man - macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol. 1991;165(2):97-103.
41. Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC. Modestly increased beta-cell apoptosis but no increased beta-cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia. 2007;50(11):2323-31.
42. Monti P, Scirpoli M, Rigamonti A, Mayr A, Jaeger A, Bonfanti R et al. Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. J Immunol. 2007;179(9):5785-92.
43. Danke NA, Yang J, Greenbaum C, Kwok WW. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects. J Autoimmun. 2005;25(4):303-11.
44. Barker JM, McFann K, Harrison LC, Fourlanos S, Krischer J, Cuthbertson D et al. Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing. J Pediatr. 2007;150(1):31-6.
45. Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP et al. Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care. 2006;29(3):643-9.
46. Stene LC, Barriga K, Hoffman M, Kean J, Klingensmith G, Norris JM et al. Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). Pediatr Diabetes. 2006;7(5):247-53.
47. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta-cell regeneration. J Clin Invest. 2007;117(9):2553-61.
48. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004;429(6987):41-6.
49. Ablamunits V, Sherry NA, Kushner JA, Herold KC. Autoimmunity and beta-cell regeneration in mouse and human type 1 diabetes: the peace is not enough. Ann N Y Acad Sci. 2007;1103:19-32. Epub@2007 Mar 21:19-32.
50. Redondo MJ, Yu L, Hawa M, Mackenzie T, Pyke DA, Eisenbarth GS et al. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001;44(3):354-62.
51. Nielsen CH, El Fassi D, Hasselbalch HC, Bendtzen K, Hegedus L. B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family. Expert Opin Biol Ther. 2007;7(7):1061-78.
52. Keenan HA, Costacou T, Sun JK, Doria A, Cavellerano J, Coney J et al. Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study. Diabetes Care. 2007;30(8):1995-7.
53. Jensen J. Pathway decision-making strategies for generating pancreatic beta-cells: systems biology or hit and miss? Curr Opin Endocrinol Diabetes Obes. 2007;14(4):277-82.
54. Turvey SE, Swart E, Denis MC, Mahmood U, Benoist C, Weissleder R et al. Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes. J Clin Invest. 2005;115(9):2454-61.
55. Harris PE, Ferrara C, Barba P, Polito T, Freeby M, Maffei A. VMAT2 gene expression and function as it applies to imaging beta-cell mass. J Mol Med. 2008;86(1):5-16.